Ligand validation:2R09

4IP: INOSITOL-(1,3,4,5)-TETRAKISPHOSPHATE

4IP is a Ligand Of Interest in 2R09 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2R09_4IP_B_400	96%	53%	0.068	0.979	0.75	1.05	-	3	2	0	100%	1
2R09_4IP_A_405	94%	53%	0.083	0.984	0.78	1.02	-	1	0	0	100%	1
2R0D_4IP_B_400	89%	55%	0.106	0.987	0.76	0.96	-	2	1	0	100%	1
1UNQ_4IP_A_1117	100%	47%	0.047	0.994	1.07	0.97	2	1	0	0	100%	1
1H10_4IP_A_1118	100%	45%	0.048	0.991	1.2	0.93	3	2	0	0	100%	1
1W1D_4IP_A_1552	97%	36%	0.063	0.978	1.21	1.29	2	5	0	0	100%	1
4KAX_4IP_B_1101	94%	57%	0.07	0.97	0.76	0.91	-	2	2	0	100%	1
5D3Y_4IP_A_501	93%	39%	0.082	0.975	0.66	1.7	-	6	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.